e-learning
resources
Vienna 2009
Tuesday, 15.09.2009
Cardiovascular complications in obstructive sleep apnoea
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Neuropeptide plasma levels in sleep apnea patients with and without excessive daytime sleepiness
M. Sánchez de la Torre, A. Barceló, M. De la Peña, S. Gómez, F. Capote, J. F. Masa, J. Durán, J. M. Marín, L. De Lecea, F. Barbé (Lleida, Madrid, Spain)
Source:
Annual Congress 2009 - Cardiovascular complications in obstructive sleep apnoea
Session:
Cardiovascular complications in obstructive sleep apnoea
Session type:
Thematic Poster Session
Number:
3692
Disease area:
Sleep and breathing disorders
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
M. Sánchez de la Torre, A. Barceló, M. De la Peña, S. Gómez, F. Capote, J. F. Masa, J. Durán, J. M. Marín, L. De Lecea, F. Barbé (Lleida, Madrid, Spain). Neuropeptide plasma levels in sleep apnea patients with and without excessive daytime sleepiness. Eur Respir J 2009; 34: Suppl. 53, 3692
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Adherence predictors to positive airway pressure (PAP) treatment in patients with obstructive sleep apnea (OSA)
The search for realistic evidence on the outcomes of obstructive sleep apnoea
PERIPHERAL ARTERIAL TONOMETRY AND INTIMA MEDIA THICKNESS IN OBSTRUCTIVE SLEEP APNEA.
Related content which might interest you:
Differences in the daytime sleepiness between sleep apnoea and hypersomnia patients
Source: Annual Congress 2008 - Assessment of sleep apnoea
Year: 2008
Ghrelin, leptin and adiponectin plasma levels in sleep apnea patients with and without excessive daytime sleepiness
Source: Annual Congress 2010 - Obesity: positive effects of bariatric surgery and exercise
Year: 2010
Pitolisant efficacy in excessive daytime sleepiness for patients with obstructive sleep apnea
Source: Sleep and Breathing Conference 2021
Year: 2021
Pitolisant efficacy in excessive daytime sleepiness for patients with obstructive sleep apnea
Source: Virtual Congress 2021 – Advances in therapeutic plans for sleep disordered breathing
Year: 2021
Sleep architecture in patients with moderate to severe sleep apnea without daytime sleepiness
Source: Annual Congress 2007 - Clinical applications of noninvasive ventilation
Year: 2007
Diagnosing excessive daytime sleepiness in obstructive sleep apnoea
Source: 5th Sleep and Breathing Conference
Year: 2019
Daytime sleepiness in patients with treated obstructive sleep apnea
Source: Eur Respir J 2007; 30: Suppl. 51, 594s
Year: 2007
The use of beta-blockers is not associated with increased daytime sleepiness in patients with obstructive sleep apnoea
Source: International Congress 2019 – Beyond continuous positive airway pressure treatment
Year: 2019
Differences in age of sleep apnea patients with normalized and persistent excessive daytime sleepiness after nCPAP therapy
Source: Annual Congress 2004 - CPAP therapy for OSA
Year: 2004
The frequency of REM related OSA among patients with mild OSA and the relation between apnea and daytime sleepiness among these patients
Source: Annual Congress 2012 - Sleep apnoea: clinical topics
Year: 2012
Residual sleepiness in obstructive sleep apnoea: phenotype and related symptoms
Source: Eur Respir J 2011; 37: 98-105
Year: 2011
Sleep and daytime sleepiness in upper airway resistance syndrome compared to obstructive sleep apnoea syndrome
Source: Eur Respir J 2001; 17: 838-847
Year: 2001
Effects of solriamfetol on real-world driving performance in participants with excessive daytime sleepiness associated with obstructive sleep apnoea
Source: Sleep and Breathing Conference 2021
Year: 2021
Evaluation of variables related with sympathetic activity in obstructive sleep apnea patients with and without excessive daytime sleepiness
Source: Annual Congress 2013 –Heart, blood and metabolism in sleep disordered breathing
Year: 2013
Daytime sleepiness and polysomnographic variables in sleep apnoea patients
Source: Eur Respir J 2007; 30: 110-113
Year: 2007
Excessive daytime sleepiness in patients with sleep-disordered breathing
Source: Eur Respir J 2008; 31: 685-686
Year: 2008
Daytime sleepiness and quality of life in patients with obstructive sleep apnea
Source: Virtual Congress 2021 – Pathophysiology and clinical consequences of obstructive sleep apnoea
Year: 2021
Long-term efficacy of solriamfetol for excessive sleepiness in narcolepsy or obstructive sleep apnea
Source: International Congress 2019 – Current perspectives in sleep-disordered breathing
Year: 2019
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept